What are the typical presentation, laboratory findings, and acute management of hyperosmolar hyperglycemic state in an older adult with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hyperosmolar Hyperglycemic State (HHS) in Older Adults with Type 2 Diabetes

Older adults with type 2 diabetes presenting with HHS typically show severe hyperglycemia (>600 mg/dL), marked hyperosmolality (>320 mOsm/kg), profound dehydration, and altered mental status without significant ketoacidosis, and require immediate aggressive fluid resuscitation with isotonic saline at 15-20 mL/kg/h as the first priority before insulin therapy. 1, 2

Clinical Presentation

Cardinal Features

  • Severe hyperglycemia: Blood glucose typically >600 mg/dL (often 800-1000 mg/dL) 3, 4
  • Marked hyperosmolality: Effective serum osmolality ≥320 mOsm/kg, calculated as [2×Na+ + glucose/18] 4, 3
  • Profound dehydration: Total body water deficit of 100-220 mL/kg (often 8-12 liters in adults) 4, 1
  • Altered mental status: Ranging from confusion to lethargy to coma, correlating with degree of hyperosmolality 5, 3
  • Absence of significant ketoacidosis: Ketones ≤3.0 mmol/L, pH >7.3, bicarbonate ≥15 mmol/L 4, 1

Unique Presentation in Elderly Patients

Older adults often present atypically, making diagnosis more challenging:

  • Blunted thirst response: Elderly patients are less likely to experience polyuria and polydipsia due to impaired thirst mechanisms and increased renal threshold for glycosuria 6, 7
  • Nonspecific symptoms: Weight loss, fatigue, confusion, and functional decline that may be incorrectly attributed to aging or dementia 6, 3
  • Normothermia or hypothermia: Despite infection being present, patients may not mount a fever due to peripheral vasodilation; hypothermia is a poor prognostic sign 1
  • High prevalence of cognitive impairment: Most HHS patients have pre-existing dementia, complicating recognition of altered mental status 3

Common Precipitating Factors

The most common precipitating factor is infection (present in 79% of elderly HHS cases), particularly:

  • Urinary tract infections and pneumonia (most frequent) 3, 1
  • Cardiovascular events: cerebral infarction, myocardial infarction 1, 7
  • Medications: corticosteroids, thiazides, sympathomimetic agents (dobutamine, terbutaline) 1, 8
  • Inadequate fluid intake: especially in nursing home residents, those living alone, or with ADL decline 3, 7
  • Newly diagnosed diabetes: 4 out of 14 cases in one elderly cohort were new diagnoses 3

Critical pitfall: Half of elderly HHS patients have a history of cerebral infarction or hip fracture, limiting their ability to access fluids independently 3

Laboratory Findings

Initial Laboratory Evaluation

The following tests should be obtained immediately 1:

  • Plasma glucose: Typically >600 mg/dL (mean 881 mg/dL in elderly) 3, 4
  • Serum osmolality: ≥320 mOsm/kg (mean 353 mOsm/kg in elderly) 3, 4
  • Electrolytes with calculated anion gap: Usually normal anion gap (<12 mEq/L) 1, 4
  • BUN/Creatinine: Markedly elevated BUN/Cr ratio (often >30) indicating prerenal azotemia from volume depletion 2, 6
  • Serum ketones: Minimal or absent (≤3.0 mmol/L) 4, 1
  • Arterial blood gases: pH >7.3, bicarbonate ≥15 mmol/L 4, 1
  • Complete blood count with differential: To assess for infection and leukocytosis 1
  • HbA1c: Mean 10.3% in elderly HHS patients; useful to distinguish acute versus chronic poor control 3, 1
  • Urinalysis and urine ketones: Minimal ketonuria 1
  • Electrocardiogram: To assess for cardiac ischemia and electrolyte abnormalities 1

Infection Workup

Bacterial cultures (blood, urine, throat) must be obtained immediately and appropriate antibiotics started if infection is suspected, as infection is the most common precipitating cause 1

A chest X-ray should be obtained given the high prevalence of pneumonia 1, 3

Ongoing Monitoring

Monitor electrolytes, glucose, BUN, and creatinine every 2-4 hours initially to assess response to fluid resuscitation and guide potassium replacement 2, 9

Acute Management

Phase 1: Initial Resuscitation (0-60 minutes)

Step 1: Aggressive Fluid Resuscitation (FIRST PRIORITY)

  • Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/h (typically 1-1.5 liters in the first hour) 1, 2
  • This is the single most important intervention and takes priority over insulin therapy 2, 4
  • Goal: Restore intravascular volume and renal perfusion to correct prerenal azotemia 2, 8

Critical pitfall: Never give insulin before adequate fluid resuscitation, as this can worsen hypotension and renal perfusion 2

Special consideration in elderly: Exercise caution with aggressive fluid replacement in patients with:

  • Congestive heart failure (necessitating avoidance of fluid excess) 7
  • Cerebral stroke (which requires anti-edema therapy) 7
  • These two precipitating factors are frequent causes of death in elderly HHS patients 7

Step 2: Potassium Assessment

  • Check initial potassium level before starting insulin 1, 9
  • Once renal function is assured, add 20-30 mEq/L potassium to IV fluids (2/3 KCl and 1/3 KPO4) 1
  • Insulin therapy will drive potassium intracellularly, risking life-threatening hypokalemia 9

Phase 2: Continued Fluid Therapy (1-6 hours)

Fluid selection after initial hour:

  • If corrected serum sodium is normal or elevated: Switch to 0.45% NaCl at 4-14 mL/kg/h 1, 8
  • If corrected serum sodium is low: Continue 0.9% NaCl at similar rate 1
  • Goal: Gradual decline in osmolality at 3.0-8.0 mOsm/kg/h to minimize risk of neurological complications (osmotic demyelination) 4, 2

Expected clinical course: With appropriate fluid resuscitation, BUN and creatinine should normalize within 24-48 hours as prerenal azotemia resolves 2

Phase 3: Insulin Therapy

Timing: Insulin should be commenced only after osmolality stops falling with fluid replacement alone, unless there is significant ketonaemia present 4

Dosing regimen:

  • Bolus: 10-15 units of regular insulin IV 8
  • Continuous infusion: 0.1 units/kg/h (fixed rate intravenous insulin infusion) 8, 2
  • Target glucose decline: 50-75 mg/dL per hour (avoid overly aggressive lowering in elderly) 2

Critical distinction from DKA: In critically ill and mentally obtunded patients, continuous IV insulin is standard of care 1. However, for uncomplicated cases, subcutaneous rapid-acting analogs combined with aggressive fluid management may be used 1

Phase 4: Glucose Management (6-12 hours)

  • Once blood glucose approaches 250-300 mg/dL (13.9-16.7 mmol/L): Add 5% or 10% dextrose to IV fluids 8, 4
  • Reduce insulin infusion rate to maintain glucose 10-15 mmol/L (180-270 mg/dL) in first 24 hours 4
  • Target glucose range: 10-15 mmol/L in first 24 hours to prevent hypoglycemia 4

Phase 5: Resolution and Transition (12-72 hours)

HHS resolution criteria 4:

  • Osmolality <300 mOsm/kg
  • Hypovolemia corrected (urine output ≥0.5 mL/kg/h)
  • Cognitive status returned to pre-morbid state
  • Blood glucose <15 mmol/L (270 mg/dL)

Transition considerations:

  • Many elderly patients presenting with HHS will not require long-term insulin therapy and can be managed with diet or oral agents, as insulin secretion capacity is often preserved 8, 3
  • In one elderly cohort, 9 out of 14 patients were treatable with oral hypoglycemic agents alone after recovery 3

Critical Pitfalls to Avoid

  1. Starting insulin before adequate fluid resuscitation: This worsens hypotension and renal perfusion 2
  2. Overly aggressive osmolality correction: Target 3.0-8.0 mOsm/kg/h decline to prevent osmotic demyelination syndrome 4, 2
  3. Ignoring potassium replacement: Insulin drives potassium intracellularly; monitor and replace aggressively 9, 1
  4. Excessive fluid in heart failure patients: Balance fluid needs with cardiac status in elderly with comorbidities 7
  5. Assuming abdominal pain is from HHS: May be precipitating cause (pancreatitis) rather than result; requires further evaluation if persistent 1
  6. Missing underlying infection despite normothermia: Obtain cultures and start antibiotics empirically if suspected 1, 3
  7. Using bicarbonate therapy: Not indicated in HHS (pH >7.3); only use if pH <6.9 in mixed DKA/HHS 9, 1

Prognosis and Outcomes

  • Mortality: HHS carries high mortality, with age being the best known prognostic indicator 7, 5
  • Functional outcomes: Even with high survival rates, functional prognosis is often impaired; in one series, 9 of 14 elderly patients were discharged to nursing homes or other hospitals 3
  • Length of stay: Mean hospitalization 55 days in elderly patients 3
  • ICU admission: These patients are critically ill and generally require intensive care unit admission 5

Prevention Strategies

The primary way to diminish mortality from HHS is prevention 7:

  • Ensure appropriate fluid intake in elderly diabetics, especially those in nursing homes or living alone 7, 3
  • Use caution with thiazides, steroids, and phenytoin in aged diabetics, particularly those with nephropathy 7, 1
  • Recognize that more than half of elderly HHS patients were living alone or only with their spouse, with marked ADL deterioration 3
  • Address social support deficits and cognitive impairment proactively 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperglycemia and Prerenal Azotemia in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Physiological Effects of Hypercalcemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diabetic non ketotic hyperosmolar state: a special care in aged patients.

Archives of gerontology and geriatrics, 1996

Guideline

Diabetic Ketoacidosis Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.